Different chronic obstructive pulmonary disease phenotypes, systemic inflammation and the risk of falls Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016
PP301 – The role of the systemic inflammation in bronchiectasis exacerbation frequency Source: ERS Lung Science Conference 2021 Year: 2021
An air-fluid level in the cavity is the sign of the exacerbation in chronic pulmonary aspergillosis Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011
Systemic inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD diagnosis Year: 2013
Evaluation of contribution of high frequency chest wall oscillation treatment to medical treatment in patients with acute exacerbations of COPD Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011
The use of high frequency chest wall oscillation during an acute infective pulmonary exacerbation of cystic fibrosis Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012
Systemic manifestations in smokers and mild/moderate chronic obstructive pulmonary disease Source: International Congress 2015 – Best abstracts in COPD management Year: 2015
The comparison of the manifestation of systemic inflammation in patients with minor forms of tuberculosis and pulmonary sarcoidosis Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009
Systemic effects of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=224 Year: 2006
The association between lung function and exacerbation frequency in patients with COPD, results from a systemic review Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009
The effect of long term low dose azithromycin on symptoms and lung function in pulmonary sarcoidosis Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008
Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013
A comparison of the effects of lung function between low dose theophylline and oral β2-agonist in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 215s Year: 2006
Systemic effects in patients with chronic obstructive pulmonary disease: a role of disease duration and disease severity Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009
Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015
The effects of nutritional status on pulmonary function, exercise tolerance and degree of dyspnea in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006
Increased small intestinal permeability during severe acute exacerbations of COPD Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016
Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 137-142 Year: 2004
The impact of a network based approach on lung function and symptom duration at diagnosis in idiopathic pulmonary fibrosis Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018
The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010